Your browser doesn't support javascript.
loading
Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40.
Langley, Richard G; Sanyal, Chiranjeev; Situ, Aaron; Alulis, Sarah; Hassan, Fareen; Peterson, Steve; Teneralli, Rachel E; Lee, Jennifer; Patel, Barkha P; Disher, Tim.
Affiliation
  • Langley RG; Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Sanyal C; Department of Community Health and Epidemiology, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Situ A; CRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, Canada.
  • Alulis S; CRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, Canada.
  • Hassan F; Tigermed BDM, Somerset, New Jersey.
  • Peterson S; Janssen-Cilag A/S, Birkerød, Denmark.
  • Teneralli RE; Janssen-Cilag Ltd, High Wycombe, United Kingdom.
  • Lee J; Janssen Immunology Global Commercial Strategy Organization, Horsham, Pennsylvania.
  • Patel BP; Janssen Immunology Global Commercial Strategy Organization, Horsham, Pennsylvania.
  • Disher T; Janssen-Cilag A/S, Birkerød, Denmark.
JAAD Int ; 15: 165-167, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38882038
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Int Year: 2024 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Int Year: 2024 Document type: Article Affiliation country: Canada